Aarhus University logo
The Danish Research Institute of Translational Neuroscience (DANDRITE) is the Danish node of the Nordic EMBL Partnership, and performs basic and translational research in brain and the nervous system.
The Institute for Molecular Medicine Finland (FIMM) is the Finnish node of the Nordic EMBL Partnership. FIMM’s research interests are human genomics and personalized medicine, with a focus on translational research.
The Laboratory for Molecular Infection Medicine Sweden (MIMS) is the Swedish node of the Nordic EMBL Partnership. MIMS aims to strengthen Swedish research and enhance the dynamics in the field of molecular medicine.
Centre for Molecular Medicine Norway (NCMM) is the Norwegian node of the Nordic EMBL Partnership. NCMM conducts molecular medicine & biotech research and works translate these findings into clinical practice.
Following a successful evaluation by NCMM’s Scientific Advisory Board (SAB) in February 2023, the Computational Biology and Systems Medicine group led by Marieke Kuijjer has been extended for four years.
DANDRITE and the Graduate School of Health at Aarhus University are hosting a nine days course focusing on neural design and its implications, from health to building computers and artificial intelligence. Among the instructors are the two authors of the course’s primary curriculum.
On 16 March 2023, the Finnish node of the Nordic EMBL Partnership for Molecular Medicine, FIMM, together with the Doctoral Program in Clinical Research at University of Helsinki, hosted the 11th Building Bridges symposium in Helsinki.
This month DANDRITE celebrates 10 years of existence. With a new generation of highly talented group leaders already recruited, the research center is ready to embark on a new decade.
Page 1 of 53.
Members of the Nordic EMBL Partnership for Molecular Medicine will be hosted in Helsinki in 2023 for the Annual Meeting. Program and more information…